Clinical Trial
Efficacy of ketotifen in bronchial asthma
- PMID: 38658
Item in Clipboard
Clinical Trial
Efficacy of ketotifen in bronchial asthma
Allergol Immunopathol (Madr).
1979 May-Jun.
Abstract
Ketotifen was administered orally during a period of three months to 30 patients suffering from bronchial asthma. It proved to be a strong antiasthmatic agent and the results obtained were positive, i.e.: Excellent in 21 patients (70%), very good in 3 patients (10%), Good in 1 patient (4%), Poor in 5 patients (16%), The drug was very well tolerated and no signs of drug toxicity were observed. It is concluded that ketotifen is a very effective and safe drug for the prevention of bronchial asthma.
Similar articles
-
The protective effect of ketotifen in bronchial asthma.J Int Med Res. 1978;6(2):78-85. J Int Med Res. 1978. PMID: 24563 Clinical Trial.
-
[Long-term therapy of bronchial asthma with ketotifen. European experiences].Schweiz Med Wochenschr. 1980 Feb 9;110(6):191-5. Schweiz Med Wochenschr. 1980. PMID: 6103579 Clinical Trial. German.
-
[An experimental and clinical study of the effect of ketotifen in the treatment of extrinsic bronchial asthma (author's transl)].Prax Klin Pneumol. 1979 Apr;33 Suppl 1:309-11. Prax Klin Pneumol. 1979. PMID: 37493 Clinical Trial. German.
-
[Ketotifen in the prevention of bronchial asthma. International therapeutic evaluation].Allergol Immunopathol (Madr). 1981;Suppl 9:177-90. Allergol Immunopathol (Madr). 1981. PMID: 6131598 Review. French. No abstract available.
-
[Ketotifen (Zaditen and K-Asthmal): a drug with sales disproportionate to its demonstrated effectiveness].Gac Med Mex. 1999 Mar-Apr;135(2):165-70. Gac Med Mex. 1999. PMID: 10327750 Review. Spanish.